Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | CDC25B | P30305 | 3/20 | 0.80 |
| ▸ | MAOA | P21397 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | APAF1 | O14727 | 2/20 | 0.65 |
| ▸ | TDP2 | O95551 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | S100A4 | P26447 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | TERT | O14746 | 1/20 | 0.65 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.65 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29402128 | 1.00 | MEN1 (0.80) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL1901249 | 0.89 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL14943 | 0.89 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL29358690 | 0.89 | MEN1 (1.00) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL6415478 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL10905960 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL9208192 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL10991985 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL8081485 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL7205968 | 0.86 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600673-B2 | Composite member, and heat generation device, building member and light emitting device, each of which uses same | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-04-14 | — | — | US | claimed |
| US-20260018687-A1 | SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2026-01-15 | — | — | US | claimed |
| CN-113024928-B | Photochromic laser color change material, preparation method and application thereof | 四川大学 | 2022-05-13 | — | — | CN | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| EP-3201675-B1 | ELECTROWETTING DISPLAY DEVICE COMPRISING A RADIATION FILTER | AMAZON TECH INC (US) | 2020-11-04 | — | — | EP | claimed |
| US-10312546-B2 | Non-aqueous liquid electrolyte for secondary battery and secondary battery | FUJIFILM CORPORATION (JP) | 2019-06-04 | — | — | US | claimed |
| US-9964870-B2 | Electrophotographic photoreceptor and image forming apparatus and image forming method using the same | Konica Minolta, Inc. (JP) | 2018-05-08 | — | — | US | claimed |
| EP-2502210-B1 | SECURITY LABEL FOR IDENTIFYING PRODUCTS | BUNDESANSTALT FÜR MAT UND -PRÜFUNG (BAM) (DE) | 2017-10-18 | — | — | EP | claimed |
| WO-2004113464-A1 | THERMALLY ACTIVATABLE REMOVABLE ADHESIVE TAPES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-12-29 | — | — | WO | claimed |
| US-20030007250-A1 | Temperature compensation of Bragg reflection gratings | FORCETEC CO., LTD. (KR) | 2003-01-09 | — | — | US | claimed |
| EP-0932131-B1 | Optical smoke detector | SIEMENS BUILDING TECH AG (CH) | 2003-01-02 | — | — | EP | claimed |
| US-6063849-A | CONTAINING PHOTOSENSISTIZER IN PHOTOELECTRIC CONTACT WITH ZINC OXIDE; FISH NETS, WATER CONDUITS, BOAT HULLS, SHOWER CURTAINS, BATHROOM FIXTURES, HOSPITAL WALLS | CAPE COD RESEARCH, INC. (US) | 2000-05-16 | — | — | US | claimed |
| US-5916947-A | WHICH HAS BEEN SURFACE COATED BY PHOTOSENSITIZER(S) WHICH INCREASE THE CAPABILITY OF ZINC OXIDE TO ABSORB VISIBLE LIGHT. | CAPE COD RESEARCH, INC. (US) | 1999-06-29 | — | — | US | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5639413-A | THREE-DIMENSIONAL OBJETS; USING AN EPOXY-FUNCTIONAL SILICON CONTAINING MONOMER | CRIVELLO JAMES VINCENT (US) | 1997-06-17 | — | — | US | claimed |
| WO-1996030182-A1 | METHODS AND COMPOSITIONS RELATED TO STEREOLITHOGRAPHY | CRIVELLO JAMES V (US) | 1996-10-03 | — | — | WO | claimed |
| WO-1996017007-A1 | ZINC OXIDE PHOTOACTIVE MATERIAL | CAPE COD RESEARCH, INC. (US) | 1996-06-06 | — | — | WO | claimed |
| US-4455741-A | Fabrication of solid state electronic devices using fluorescent imaging of surface temperature profiles | AT&T BELL LABORATORIES (US) | 1984-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260018687-A1 | SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS | CTCF, EBP, AS3MT | MEN1 4422/4885KMT2A 410/4885CDC25B 3171/4885 |
| US-12600673-B2 | Composite member, and heat generation device, building member and light emitting device, each of which uses same | ILK, PIEZO1, TRPA1 | MEN1 684/4885KMT2A 4482/4885CDC25B 4341/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | MEN1 2055/4885KMT2A 4561/4885CDC25B 3620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.